French health insurance innovator Alan has secured a landmark €480 million in a Series G funding round, elevating its valuation to an impressive €5.5 billion. This significant capital injection, led by global technology investor Prosus, will fuel the company's mission to expand its prevention-focused healthcare model internationally. The funding underscores strong investor confidence in Alan's vision to transform the traditional health insurance landscape.
A Landmark Funding Round
The funding round was spearheaded by the Dutch investment fund Prosus, which now joins Alan's capital table alongside new British investor Dara Holdings. They are accompanied by historical shareholders Teachers' Venture Growth and Index Ventures, who reaffirmed their commitment to the company's growth trajectory. This operation, Alan's largest to date, solidifies its status as one of the most valuable scale-ups within the French Tech ecosystem.
Fueling International Expansion and Innovation
Alan has outlined a clear strategy for deploying the new capital, with international expansion as a primary objective. The company plans to strengthen its presence in existing markets like France, Belgium, Spain, and Canada while also entering a new country by 2027. Furthermore, the funds are earmarked for pursuing targeted acquisitions and continuing to invest heavily in product innovation to enhance its user experience.
Artificial intelligence is a cornerstone of Alan's strategy to democratize access to personalized health services and drive operational efficiency. The company's AI medical agent, "Mo," is already used by one in ten members weekly, demonstrating strong user adoption and engagement. This technological focus also enables remarkable efficiency, with 70% of reimbursement claims processed in under five minutes, setting a new industry standard.
Strong Financials and a Path to Profitability
This investment is built upon a foundation of exceptional growth, with Alan reporting over €800 million in annual recurring revenue, a year-over-year increase of more than 50%. While the company recorded a group-level loss last year, this reflects a deliberate strategy to reinvest in product development and market expansion. This approach prioritizes long-term growth and market capture over immediate, comprehensive profitability across all regions.
The company's financial trajectory is showing strong positive momentum, having recently achieved profitability in its largest market, France. This milestone is a significant proof point for its business model, as the French market constitutes over three-quarters of its activity. With this success, Alan has set a clear goal to achieve profitability at the group level by 2027.
Redefining Health Insurance with Prevention
At the core of Alan's mission is a fundamental shift away from the reactive nature of traditional health insurance toward a proactive, prevention-centric model. The company aims to be more than just an insurer by integrating prevention, care navigation, and personalized AI-driven assistance into a single platform. This holistic approach is designed to keep members healthier and reduce long-term healthcare costs for everyone involved.
To realize its vision of an integrated health system, Alan has expanded its offerings beyond core insurance coverage. Its application now includes features such as "Shop," a marketplace for health and wellness products, and "Walk," a gamified step counter. These services, alongside the AI assistant "Mo," embody the company's ambition to become a comprehensive health partner for its 1.1 million members.
This €480 million funding round marks a pivotal moment for Alan, providing the necessary resources to scale its innovative vision on a global stage. The investment validates the company's prevention-first model and its successful integration of technology to create a more accessible and proactive healthcare experience. With the backing of prominent global investors, Alan is poised to continue its disruption of the health insurance industry.